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Abstract
Background: Misexpression of the double homeodomain transcription factor DUX4 results in facioscapulohumeral
muscular dystrophy (FSHD). A DNA-binding consensus with two tandem TAAT motifs based on chromatin IP peaks
has been discovered; however, the consensus has multiple variations (flavors) of unknown relative activity. In
addition, not all peaks have this consensus, and the Pitx1 promoter, the first DUX4 target sequence mooted, has a
different TAAT-rich sequence. Furthermore, it is not known whether and to what extent deviations from the
consensus affect DNA-binding affinity and transcriptional activation potential.
Results: Here, we take both unbiased and consensus sequence-driven approaches to determine the DNA-binding
specificity of DUX4 and its tolerance to mismatches at each site within its consensus sequence. We discover that
the best binding and the greatest transcriptional activation are observed when the two TAAT motifs are separated
by a C residue. The second TAAT motif in the consensus sequence is actually (T/C)AAT. We find that a T is preferred
here. DUX4 has no transcriptional activity on “half-sites”, i.e., those bearing only a single TAAT motif. We further find
that DUX4 does not bind to the TAATTA motif in the Pitx1 promoter, that Pitx1 sequences have no competitive
band shift activity, and that the Pitx1 sequence is transcriptionally inactive, calling into question PITX1 as a DUX4
target gene. Finally, by multimerizing binding sites, we find that DUX4 transcriptional activation demonstrates
tremendous synergy and that at low DNA concentrations, at least two motifs are necessary to detect a
transcriptional response.
Conclusions: These studies illuminate the DNA-binding sequence preferences of DUX4.
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Background
Facioscapulohumeral muscular dystrophy (FSHD) is argu-
ably the most prevalent genetic disease of muscle [1, 2]. It
is caused by altered regulation of the subtelomeric chr4q
macrosatellite repeat, D4Z4 [3–6]. This 3.3-kb macrosatel-
lite sequence is typically present in ~30 tandem copies [7],
while most cases of FSHD involve array contractions
bringing the number of tandem repeats down to 10 or
fewer [8, 9]. When this occurs, the array, which is
normally silent through a poorly understood repeat-
induced silencing mechanism, becomes transcriptionally
active [10, 11]. Alternatively, the array can become tran-
scriptionally active through second site mutations in genes
required for repeat-induced silencing, for example,
SMCHD1 [12–14]. When this happens in the context
of an allele that provides a downstream polyA signal
[15], a muscle pathology ensues.
The D4Z4 repeat contains an open reading frame en-
coding DUX4, a double-homeodomain transcription fac-
tor [16]. The DUX4 protein is quite difficult to detect in
FSHD clinical specimens [17, 18], but its presence can
be read out indirectly in both proliferating and differen-
tiating myoblasts, with slightly greater expression in the
latter [19, 20]. When induced at low levels of expression
in myogenic progenitor cells, DUX4 interferes with
MyoD expression and impairs myogenic differentiation
[21, 22]. High levels of DUX4 expression promote cell
death [22, 23]. As the homeodomains of DUX4 fall
within the paired homeodomain class, and indeed are
very close in sequence to those of the skeletal muscle
stem cell regulators Pax3 and Pax7 [24, 25], a model
suggesting that skeletal myogenic phenotypes in FSHD
may be due in part to competition with Pax3/7 for
* Correspondence: kyba@umn.edu
1Lillehei Heart Institute, University of Minnesota, Minneapolis, MN 55455, USA
2Department of Pediatrics, University of Minnesota, Minneapolis, MN 55455,
USA
Full list of author information is available at the end of the article
© 2016 Zhang et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhang et al. Skeletal Muscle  (2016) 6:8 
DOI 10.1186/s13395-016-0080-z
targets was proposed [22]. Supporting this possibility,
overexpression of either Pax3 or Pax7, but not the more
distantly related homeodomain protein HoxB4, signifi-
cantly reduced the cytotoxicity of DUX4 [22]. The se-
quence binding preferences of both DUX4 and Pax3/7
have recently been described through interrogation of
sequences falling under ChIP-seq peaks [11, 26]. Al-
though both sequences contain TAAT core motifs, they
differ in that the DUX4 consensus site contains two
TAAT motifs in tandem, while the Pax3/7 site contains
the motifs in a head-to-head orientation (i.e., TAAT
followed by ATTA). Besides binding sequences identified
through ChIP-seq, DUX4 binding to a sequence in the
promoter of Pitx1 had been demonstrated by band shift
assays [10, 27]. The Pitx1 sequence does not contain a
tandem TAAT motif, but rather has two overlapping
head-to-head motifs: TAATTA, and this motif is also
present in the human PITX1 gene. Thus, from work to
date, it is not entirely clear what sequences DUX4 can
bind to. Specific tests comparing DUX4 activity on dif-
ferent flavors of target sequences have never been done.
Because of the central role that DUX4 plays in FSHD, an
understanding of the DNA-binding activity of DUX4 is es-
sential to a mechanistic understanding of the disease. We
have taken unbiased and candidate-selected approaches to
compare the DNA-binding and transcriptional enhancing
activity of DUX4 on various known sequences as well as
randomly generated variants. Using the DNA element of
greatest potency, we also investigate the copy number de-
pendency of transcriptional activation by DUX4.
Methods
Reporter constructs
The luciferase reporter construct pGL4-12X-DUX4 con-
taining 12× DUX4 binding motifs (CT flavor: TAATC-
TAATCA) was synthesized by GENEWIZ (New Jersey)
and subcloned into XhoI/HindIII linearized the pGL4-
Amp luciferase plasmid (Promega) using T4 ligation. To
generate the 6× reporter, pGL4-6X-DUX4 6 motifs were
removed from this construct using KpnI digestion,
followed by T4 ligation. To generate the 24× construct,
pGL4-24X-DUX4, we ligated an XhoI/SalI fragment
from pGL4-12X-DUX4 into XhoI linearized pGL4-12X-
DUX4 plasmid and the correct orientation selected. All
other luciferase plasmids were constructed by T4
ligation of XhoI/HindIII linearized pGL4-Amp(R)
luciferase plasmid with corresponding PCR-amplified
fragments using In-Fusion HD cloning (Clontech). PCR
fragments and primer information are listed in
Additional file 1: Table S1.
Generation of DUX4-inducible 293T cells
FUIGW-rtTA was constructed by inserting rtTA2(s)-m2
(amplified by PCR) into BamH1/EcoR1 FUIGW (Lyu et al.
2008). pSam2-iDUX4-Flag-UBC-puro, the doxycycline-
inducible DUX4 lentivector, was generated in the follow-
ing way: The polyA signal from SV40 was amplified from
p2lox (Iacovino et al. 2011) and inserted into pSAM2
(Zhang et al. 2011) at the Not1 site. The Ubiquitin C pro-
moter and EGFP from FUGW (Lois et al. 2002) was then
inserted into Pac1/BsrG1-digested plasmid, replacing the
sgTRE promoter. The puromycin resistance gene
(PAC) was PCR amplified and used to replace GFP by
in-fusion cloning (Clontech). DUX4 with a c-terminal
Flag peptide was PCR amplified and inserted into
EcoR1/Not1 digested plasmid to generate pSam2-
iDUX4-Flag-Ubc-Puro.
Transfection and luciferase assays
Prior to transient transfection, DUX4-inducible 293T
cells were plated in 96-well dishes until cells reached
60 % confluency. Each well of cells was transfected with
95 ng of pGL4 firefly luciferase reporter plasmid to-
gether with 5 ng of Renilla luciferase control plasmid
using TransIT-LT1 transfection reagent (Mirus Bio
LLC). Doxycycline (500 ng/ml) was added into each well
after 24-h post-transfection to induce DUX4 expression,
and cells were lysed 48 h post-transfection for luciferase
assays using the Dual-Glo Luciferase Assay System (Pro-
mega). For luciferase assays, 75 μl of Dual-Glo luciferase
assay reagent was added to each well and incubated at
room temperature for 15 min before measuring the fire-
fly luminescence. After measuring, 75 μl of Dual-Glo
Stop & Glo reagent was added into each well and incu-
bated at room temperature for 15 min to quench the
firefly luciferase activity, after which Renilla lumines-
cence activity was measured. Luminescence readouts
were measured using Cytation 3 plate reader (Bio-Tek)
under luminescence fiber mode with the Gain-value
fixed at 135. Firefly luminescence was first normalized
to Renilla luminescence and scaled to fold of induction
to the control well (no dox addition). Each reporter ana-
lysis was done in triplicate and repeated twice.
Bacterial expression of the DUX4 N-terminus
The N-terminus of DUX4, containing the two homeodo-
mains was expressed in bacteria using the plasmid
pET28 with a tobacco etch virus nuclear inclusion A
endopeptidase protease (TEV) site engineered between
the His6 tag and protein. We altered the codon usage,
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and subcloned into the vector.
The DUX4-HD protein was produced in BL21(DE3)
and purified by Ni-NTA IMAC affinity purification. The
recombinant DUX4 protein (containing the N-terminal
His6 tag) was cleaved off with TEV protease, and the
final protein was purified by size exclusion chromatog-
raphy (Superdex 200). For later experiments, we used a
His-tagged SUMO-fusion construct (pE-SUMO, LifeSen-








Band shift experiments were performed with double















In a final volume of 30 μL, 10 μL of 100 μM probe was
mixed with 20 μL of 250 μM DUX4 HD protein (in
500 mM NaCl, 20 mM Tris-Cl, pH 7.4). Samples were
incubated on ice for 1 h, then run immediately on a 3 %
agarose gel containing 0.5 μg/ml EtBr.
Competitive band shifts Ten microliters of 100 μM
probe was added to 16 μL of milliQ H2O; 2 μL of DUX4
HD protein (125 μM in 50 % glycerol, 250 mM NaCl,
10 mM Tris-Cl, pH 7.4) was then added, followed by
2 μL of 100 μM FAM-labelled CT probe (final volume of
30 μL). Samples were incubated on ice for 1 h, then run
immediately on a 3 % agarose gel, with no EtBr.
SELEX-seq: DNA pulldown assays
We synthesized the following partially randomized single
stranded oligonucleotides:
Synthetic Bait-1 target: TCGTCGGCAGCGTCA-
GATGTGTATAAGAGACAGNNNNNNNNTAATNNN
NNNNNCTGTCTCTTATACACATCTCCGAGCCCAC
GAGAC (underlined sequences represent Nextera
adapter sequences).




A’ refers to a mixture of 91 % dATP, and 3 % each of
the other deoxynucleotides and so on for T’, C’, and G’.
We generated double-stranded oligonucleotide from
these using 15 cycles of amplification with the following
primers: BaitF: TCGTCGGCAGCGTC, BaitR:
GTCTCGTGGGCTCGG.
Prior to DNA pulldown, 250 ng of His-tagged DUX4
DNA-binding domain was incubated with 50 μl of Ni-
NTA resin (Thermo Scientific) in 500 μl of NT2 buffer
(20 mM Tris-HCl (pH 7.5), 100 mM NaCl, 0.05 % Noni-
det P-40) at 4 °C for 30 min, followed by three washes
using 500 μl of NT2 buffer. Then, 3 μg of bait DNA was
incubated with resin-protein complex in 250 μl of bind-
ing buffer (20 mM Tris-HCl (pH 7.5), 100 mM NaCl,
0.05 % Nonidet P-40, 0.5 mM EDTA, 100 μg/ml BSA,
35 μg of poly(dI-dC)) at room temperature for 15 min,
followed by six washes using 500 μl of NT2 buffer [28].
Pulled down DNA was then eluted by boiling and
amplified again for a second cycle of systematic evolu-
tion of ligands by exponential enrichment (SELEX). For
bait1, we performed 5 cycles of pulldown; for Bait-2, we
performed 3 cycles. For sequencing, the product was
amplified for 10 cycles using different combinations of
indexing primers
Bait-1 input: N501-N701; Bait-1 output: N501-N702;
Bait-2 input: N501-N704; Bait-2 output: N501-N705.
Forward indexing primer, N501: AATGATACGGCGAC-
CACCGAGATCTACACTAGATCGCTCGTCGGCAGC







Fifty 2.5 M base paired-end reads were then generated
for each sample on an Illumina HiSeq Instrument.
Analysis of SELEX-seq data
The Bait-1 SELEX-seq data was analyzed using the
SELEX Bioconductor package [29]. A fifth-order Markov
model was constructed using control Bait-1 sequences
(no DUX4 pulldown) to predict the number of 16-mer
sequences in each initial library as described [30, 31]. Se-
quence counts from the DUX4 pulldown of Bait-1 were
compared expected counts as predicted using Markov
model derived from control data to identify significantly
enriched sequences. The top 20 enriched putative DUX4
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binding sequences each contained one of the four 11 bp
sequences described in Fig. 3.
Results
Measuring DUX4 transcriptional activation on identified
target sequences
ChIP-seq analysis has identified a consensus containing
two tandem TAAT motifs (TAAT[T/C][T/C]AATCA)
[11]; however, the relative activity of DUX4 for the four
individual motifs that match this consensus is unknown.
We therefore began by transfecting luciferase reporters
containing a single motif upstream of a minimal pro-
moter on to 293T cells that we modified for
doxycycline-inducible DUX4 expression. We also tested
the activity of half-sites, having only the second TAAT
motif with the terminal CA. This analysis showed that
although all four variants could be recognized by DUX4,
resulting in dox-dependent luciferase induction, the
motif containing a central cytosine followed by a thymi-
dine (TAATCTAATCA) had the greatest transcriptional
activity in vivo (Fig. 1a). We therefore used this as our
baseline positive control for other experiments. Half-
sites did not show luciferase induction, although dupli-
cating the CAATCA half-site apparently created a bind-
ing site for an unknown DUX4-unrelated activator (seen
by dox-independent high level of background).
We next tested the activity of other putative DUX4-
binding DNA sequences. The first sequence to which
DUX4-binding was attributed was in the promoter of
the murine Pitx1 gene [10]. Two publications have
shown band shift activity in nuclear extracts of cells
transfected with DUX4 expression vectors [10, 27]. The
similarity of the DUX4 homeodomains to those of Pax3
and Pax7 [22] which recognize TAAT sequences sug-
gested that DUX4 might recognize a TAAT sequence
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Fig. 1 DUX4-dependent luciferase activity of the four flavors of the DUX4 ChIP-seq motif. a DUX4 dose dependence of the four flavors of the
DUX4 ChIP-seq consensus (left) and “half-sites” in one or two copies (right). RLU, relative luciferase units (normalized to Renilla luciferase).
b DUX4-induced expression of luciferase reporters bearing various previously described DUX4 recognition motifs and mutations. Fold change
is shown above each pair of assays. Note the log scale
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studies does contain a TAAT, but it is quite different
from the ChIP-seq motif, described above. It is actually
two overlapping TAATs on different strands (i.e.,
TAATTA); therefore, we generated a luciferase reporter
containing one copy of the full 30-bp sequence used in
these studies. It has also recently been shown that FRG2,
a gene upregulated in FSHD, has motifs recognized by
DUX4 [32]; we included the motif of greatest match to
the consensus motif in our comparison: TAACC-
TAATTA. We also included a sequence from the MaLR
repetitive element that is a near match to the consensus
(TAATTGAATCA, note the middle G which deviates
from the consensus) because a number of DUX4 targets
have ChIP-seq peaks in nearby MaLR elements [11, 33].
Because of recent mobility of MaLR, a subset of MaLR
integrations are not shared between human and mouse,
leading to concerns that a mouse model may not capture
some relevant DUX4 target genes. One of the most
strongly induced DUX4 target genes, ZSCAN4, has three
potential DUX4 motifs. We included each of these mo-
tifs in our analysis. To complete this collection, we in-
cluded two mutants in which the space between the two
TAATs was increased or decreased by a single base, as
well as the reverse complement of the control CT se-
quence to test the orientation dependence of the motif.
The effect that background sequence may have on
DUX4 binding is unknown, therefore, with the exception
of the second and third ZSCAN4 motifs, all of these se-
quences were embedded into the background sequence
flanking the first ZSCAN4 motif.
Cells were exposed to a relatively high dose of doxycyc-
line (dox, 250 ng/ml) and transfected with each reporter
(Fig. 1b). In the presence of dox, the control TAATC-
TAATCA sequence gave about 8-fold higher expression
over background, and the reverse complement gave about
6-fold increased expression, demonstrating orientation in-
dependence of transcriptional activation by DUX4. Other
active sequences included those from FRG2 (~3-fold),
MaLR (2.4×), and motifs 1 and 3 from ZSCAN4 (~3× and
13×, respectively) ZSCAN4 motif 2, in which the A from
the first TAAT was substituted, was inactive. The Pitx1 se-
quence gave no activity. Neither did sequences in which
the spacing between the two TAAT motifs was increased
or decreased by a single base pair.
Physical interaction between the DUX4 homeodomains
and DNA
The lack of induction by the 30-bp Pitx1 sequence was
surprising, as it had previously been shown to interact
with DUX4 in band shift assays. However, to date, pub-
lished band shifts have been with nuclear extracts, not
with purified protein. Therefore, given the striking lack
of the consensus motif within the Pitx1 sequence, we
hypothesized that the previously documented band shifts
might not be the result of a direct interaction with
DUX4. We therefore expressed the DNA-binding N-
terminal domain of DUX4, which contains both homeo-
domains, in Escherichia coli and tested the ability of the
DUX4 DNA-binding domain to directly interact with
the various target sequences studied above (studies on
full-length DUX4 were precluded by the insolubility of
the bacterially purified full-length protein). We synthe-
sized a series of double-stranded oligos, all of which
contained the putative DUX4 interaction motif within
the context of the same arbitrary identical 14 bp of
flanking sequence. Because the previously studied Pitx1
sequence is 30 bp, we selected the central putative
DUX4-interacting 13 nucleotides, containing the
ATTAAT sequence, but we also tested the full 30-bp se-
quence independently. It is important to note that al-
though the core ATTAAT sequence is conserved in the
human PITX1 gene, there are several sequence differ-
ences outside of this core.
When this set of double-stranded oligos was simply
mixed with excess protein, the band shift behavior of
these sequences correlated roughly with their transcrip-
tional activation potential: sequences that conferred
DUX4-dependent luciferase induction also robustly
shifted the probe, i.e., virtually all DNA was shifted, leav-
ing no or almost no free probe (optimal “CT” motif and
MALR, Fig. 2a). Note that the only molecules in this ex-
periment are the protein and the DNA (visualized by
ethidium bromide staining); therefore, the interaction is
direct. The mutated DUX4 site, the half-site (i.e.,
TAATCA only) and the Pitx1 core sequence in the con-
text of the 25mer oligo all showed no shift. On the other
hand, the motifs with a single base insertion or deletion
as well as the full 30-bp Pitx1 oligo showed some band
shift activity, albeit with a significant unshifted band.
To more deeply investigate the relative affinity of
DUX4 for these sequences, we performed competition
experiments, in which we fluorescently labeled the “CT”
consensus sequence (i.e., TAATCTAATCA) with FAM
(carboxyfluorescein) and competed with the unlabeled
sequences described above. For these experiments, the
protein was limiting, thus even without competitor, only
about 50 % of the FAM-labeled probe was shifted. When
unlabeled and added in excess, all four flavors of the
DUX4 ChIP-seq motif competed equally well (Fig. 2b).
However, when the other unlabeled sequences described
above were used in excess, outside of the CT control,
only the MaLR sequence displayed competitive activity,
and it was less competitive than the CT control (Fig. 2c).
Thus, while the insertion and deletion mutants and the
Pitx1 30-bp oligo do have some ability to interact with
DUX4 when the protein is in excess, when the protein is
not in excess, these sequences cannot effectively com-
pete for interaction with DUX4.
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Determination of DUX4-binding preferences by SELEX
The experiments described above suggested that DUX4
interacts with variations on the double TAAT motif. To
get a better sense of specific sequence preferences, we
performed two SELEX-seq experiments. In the first ex-
periment, we synthesized an oligo library based on the
“TT” flavor of the ChIP-seq defined consensus: TAATT-
TAATCA, and at each base, we introduced an error rate
of 9 % (i.e., 91 % of the correct nucleotide, 3 % of each
incorrect nucleotide). We used the bacterially produced
purified double homeodomain fragment to pull down
this partially randomized oligo, and PCR amplified the
pulled down products. In order not to completely lose
lower-affinity sequences, we reiterated only to cycle 3
(Fig. 3a, Bait-2). A control, not pulled down sample, was
also amplified three times to parallel the amplification to
which the pulled down oligos were subjected. Following
the third amplification, pulled down fragments were se-
quenced to a read depth of 2.5 M and the frequency of
each base at each position was compared in the pulled
down vs. control library. At every position except for
position 5 (the nucleotide between the two TAATs), the
ratio was >1, meaning that the consensus sequence was
selected over the possible mutants (Fig. 3b). At position
5 however, a strong preference for C rather than T was
observed. Thus, the CT consensus, the most transcrip-
tionally active of the four flavors initially tested (Fig. 1a),
was also the most preferred sequence in this partially
randomized library. Position 4 showed a detectable, but
weaker, preference for C. This preference was not strong
enough to result in selection against the consensus T at
position 4 (the ratio for T was still just above 1), but the
C was clearly positively selected, and preferred over A or
G. In addition to preferences within the 11-bp defined
motif, we identified preferences for sequence flanking
the motif. Most obviously, G was selected against at all
three upstream and downstream positions, while there
was a moderate preference for A and T at these
positions.
In the second SELEX-seq experiment, our objective
was to determine whether there were other sequences,
not involving the double TAAT motif, with which DUX4
could strongly interact. Based on the preference of indi-
vidual paired class homeodomains for a TAAT sequence
[34], we randomized sequence around a core TAAT
motif. We performed pulldowns of these oligos, PCR
amplified, and reiterated four times (Fig. 3a, Bait-1).
After the fifth pulldown, DNA was sequenced, as above.
We analyzed these sequences using a SELEX analysis
Bioconductor package (see the “Methods” section) and
identified enriched motifs. The top selected motif turned
out again to be the CT consensus (TAATCTAATCA).
The next two were similar to the ChIP-seq consensus,
and the fourth was a sequence that did not resemble a
double TAAT. We tested each of these sequences in lu-
ciferase reporter (Fig. 3c) and direct and competitive
band shift (Fig. 3d, e) assays. The top two SELEX motifs
showed transcriptional activation activity as well as
strong direct and competitive band shift activity, with
the CT consensus not surprisingly giving the greatest
A
B C
Fig. 2 Evaluating protein-DNA interaction by electrophoretic mobility shift. a Direct band shift assays for various sequence motifs. The DNA is
detected by EtBr staining. The CT probe contains the control TAATCTAATCA sequence and shows a complete shift to the slower-migrating form
in the presence of an excess quantity of the DUX4 DNA-binding domain. Other oligos showed various shift efficiencies. b Competitive band shifts
of the four flavors of the DUX4 ChIP-seq consensus motif. The CT probe is labelled with FAM; thus, the gel has no EtBr, and binding is competed
with unlabeled oligos. All four flavors of the DUX4 ChIP-seq consensus effectively compete away binding to the FAM-CT probe when provided in
excess, while the mutant sequence fails to compete. c Competitive band shifts of the sequences tested for direct band shifting (in a, above)
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activation and the best competition. The third motif,
three mutations away from any ChIP-seq consensus,
showed no transcriptional activity, weak band shift
activity, and very weak competitive activity, while the
fourth SELEX motif showed no activity in any assay.
Thus, the second SELEX experiment did not find
B
C
Bait-1 Pull-down Bait-2 Pull-down
1st 3rd 5th 1st 2nd 3rd
MNeg Neg
D













SELEX-1  (TAATCTAATCA = CT motif)
SELEX-2  (TAATTCAATCC)


















Fig. 3 Discovery of DUX4-interacting motifs by SELEX. a PCR assay after indicated rounds of DNA pulldown. Filled triangle indicates the specific
band; open triangle indicates primer dimers. Note that the amplified product is enriched over primer dimers by the last cycle shown. b Selection
bias for each base at each position (base frequency in the pulled down sequence/base frequency in the control). c Luciferase reporter assays for
the top four SELEX-identified sequences. d Direct band shift assays for the top 4 SELEX motifs. e Competitive activity of the top four SELEX motifs.
Each unlabeled SELEX probe was used to compete the shift of a FAM-labeled probe bearing the CT motif
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alternative motifs distinct from the double TAAT motif
defined by ChIP-seq and furthermore independently
identified the CT consensus as the most favorable of all
randomly generated sequences.
Synergy and spacing of clustered DUX4 binding sites
With multiple independent lines of evidence pointing to
the CT flavor of the DUX4 motif being the most pre-
ferred DNA-binding sequence, we next multimerized
the CT motif and evaluated whether targeting multiple
copies of DUX4 upstream of a minimal promoter would
have additive or synergistic effects on transcription. This
was motivated by the observation that many upregulated
DUX4 target genes, for example, FRG2 and ZSCAN4,
have multiple motifs to which DUX4 can bind [11, 32].
We generated reporters bearing 2, 6, 12, or 24 copies of
the CT motif and evaluated dox-dependent luciferase ac-
tivity in DUX4-inducible 293T cells. With transfection
conditions optimized for detecting activity of the single
copy reporter, additional copies of the DUX4-binding se-
quence clearly had a synergistic effect, seen most clearly
going from one copy to two copies, where two copies
were ~20-fold more potent than a single copy at the
highest concentration of dox (Fig. 4a). Adding additional
copies increased expression, but this effect plateaued at
six copies. However, when much lower amounts of DNA
were transfected, which gave no detectable expression of
the single copy reporter, more copies clearly made for a
much more sensitive reporter, and this effect did not
plateau up to 24 copies (Fig. 4b), indicating that the pre-
vious peak at 6 copies was due to the amount of protein
being limiting for the amount of DNA used.
The nature of the cooperativity seen with two sites
could mean that two DUX4 molecules bind coopera-
tively, or it could simply be due to increased avidity for a
DUX4-interacting transcriptional coactivator. To investi-
gate the first possibility, we generated a series of con-
structs in which the spacing between the two sites was
varied (Fig. 4c). The previous multimer experiments
inserted 10 bp, approximately one full helical turn, be-
tween each 11-bp motif, meaning that neighboring
DUX4 proteins are binding on the same side of the
DNA molecule. First, we placed two CT motifs directly
adjacent to one another. This construct behaved like a
single site, suggesting that DUX4 occupies a footprint
greater than the 11 bp that define its sequence specifi-
city. We then generated a series of constructs with spa-
cing increased in increments of half-turns: 15 bp,
forcing the second DUX4 molecule to the opposite side
of the DNA strand, and 20 bp, doubling the distance be-
tween the two DUX4 molecules. The transcriptional ac-
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Fig. 4 Evaluating reporters with multiple DUX4 binding sequences. a Dose-dependent activity of reporters with 1–24 copies of the CT motif at
100 ng of DNA/well. Note the logarithmic scale. b Dose-dependent activity of the same reporters at 4 ng/well. Synergy is demonstrated by the
presence of activation with the 2× reporter but its absence with the 1× reporter at this concentration, as well as the continued increase in activity
as copy number increases to 24×. c Transcriptional activity of reporters with two CT motifs spaced at different distances (indicated), compared to
a reporter with a single CT motif
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equivalent, suggesting that inter-molecular interactions
of neighboring DUX4 molecules do not explain
cooperativity.
Discussion
These studies have revealed a number of interesting
properties of the DUX4 protein. First, multiple lines of
evidence point to the CT motif, TAATCTAATCA, as
the most preferred and most transcriptionally active of
sequences that match the DUX4 consensus, previously
defined by interrogation of sequences under DUX4
ChIP-seq peaks [11]. Both a direct comparison of all
four flavors of the consensus sequence and two different
random screens based on the pulldown of DNA se-
quences by the DUX4 DNA-binding domain showed the
CT motif to be the most active.
Second, one of the sequences historically used to
measure DUX4 activity, a DNA sequence from upstream
of the mouse Pitx1 promoter, has little activity in the as-
says used here. It is possible that various optimizations
could bring out some weak activity, and indeed, the full
30-bp oligo used in previous studies had some modest
band shift activity in our hands (although no competitive
activity), but in direct comparisons with various motifs
based on the double TAAT sequence, the Pitx1 sequence
was inactive. Combined with the fact that this 30-bp se-
quence is not completely conserved between mouse and
human, that the expected ChIP-seq peak was not found
over the region corresponding to this 30-bp sequence in
humans, or anywhere near PITX1 [11], and the fact that
PITX1 was not found to be strongly upregulated by
DUX4 in various human cell systems [11, 19] (or even
mouse systems [22, 35, 36]), these data argue strongly
against the model in which FSHD is caused by DUX4-
mediated overexpression of PITX1 [10].
Third, we find that single copies of DUX4 motifs are
relatively ineffective at inducing transcription of target
genes compared to double (or greater) copy numbers.
This has implications for the relevance of mouse models
for FSHD. It has been argued that the recent mobility of
MaLR elements, which contain a single DUX4 motif,
makes mouse a less than ideal model system to study
DUX4 pathology, because the DUX4 binding sites cre-
ated by a subset of these elements are in different places
in the mouse genome compared to the human genome.
Although the MaLR motif is a relatively strong individ-
ual motif, the fact that it is present only once within the
MaLR repeat means that most MaLR-associated DUX4
binding sites do not have the capacity for high level
DUX4-mediated target gene expression. Although indi-
vidual DUX4 transcriptionally responsive sites have been
identified within primate-specific MaLR set [33], there is
nevertheless a large and significant overlap between the
sets of mouse and human DUX4-responsive genes [37].
These considerations argue that the mouse is not par-
ticularly disadvantaged as a model organism in which to
study FSHD.
The paired class of homeodomain proteins typically
bind DNA as dimers, in which each homeodomain inter-
acts with a TAAT sequence [34]. The dimer is symmet-
rical over the DNA axis; therefore, the second
homeodomain of the dimer binds over the reverse
compliment, i.e., ATTA. Thus, paired class homeodo-
mains recognize the palindromic TAAT-NX-ATTA, and
the orientation of the two homeodomains can be de-
scribed as “head to head”. The gap between the TAAT
and ATTA may be two nucleotides (a “P2” site), as in
the case of Pax7 [26], or three nucleotides (a P3 site), as
in the case of Pax6 [31]. It is tempting to speculate that
because the DUX4 homeodomains are physically con-
nected by only a short linker peptide, this might force
the homeodomains to bind DNA in a head-to-tail fash-
ion, meaning that the DUX4 motif could be considered
an N1 site, i.e., a non-palindromic TAAT pair with a
single-gap nucleotide. On the other hand, the 11-bp rec-
ognition sequence for DUX4 is the correct size for a P3
sequence, albeit one with a mismatch in position 10,
rendering the ATTA into ATCA. Because the two home-
odomains of DUX4 seem to have arisen from an internal
duplication and are more similar to each other than to
any other homeodomains, it seems improbable that they
would recognize different core sequences. We await the
structure of the DUX4-DNA complex to shed light on
this question.
In the course of our study, we discovered certain se-
quences that have band shift activity when the protein is
in excess, but failed to compete effectively when the pro-
tein is limiting and generally had no transcriptional ac-
tivity. Because the DUX4 DNA-binding domain is
actually two adjacent DNA-binding domains, we specu-
late that such band shifts may be due to DNA recogni-
tion by a single homeodomain only. Because half-sites
did not have band shift activity, only certain TAAT se-
quences have this potential, most likely ones where the
surrounding sequence tolerates and does not block posi-
tioning of the second homeodomain. This may open up
an avenue for therapy development: if small molecules
could be found that alter the interactions between the
two homeodomains or between a homeodomain and
DNA to stabilize such non-productive DNA binding,
they might alter the DNA-binding specificity of DUX4
and thus diminish its toxicity.
Conclusions
These studies demonstrate that the optimal DNA se-
quence preferred by DUX4 is the 11mer TAATC-
TAATCA (the CT motif ). Other than a weak band shift
seen when protein is in molar excess, DUX4 does not
Zhang et al. Skeletal Muscle  (2016) 6:8 Page 9 of 11
interact physically or functionally with the Pitx1 promoter
sequence, but it does interact with numerous variants of
the optimal CT motif. Although transcriptional activation
by DUX4 on targets with a single DUX4-binding motif is
relatively weak, DUX4 shows tremendous synergy when a
two or more sites are present in the same target. This im-
plies that animal species such as mice, with partially diver-
gent MaLR repeats (which carry single motifs only), are
not more particularly disadvantaged for reasons over and
above their conventional genetic divergence from humans,
with regard to their suitability for modeling the physio-
logical effects of DUX4 expression.
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